Finance Watch: Braveheart Launches With $185m To Start Late-Stage Trials

Resilience Secured $825m In Debt Funding

 
• By Mandy Jackson
  
Finance Watch Private Company
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Finance Watch